TreeWAS – Variant ID: rs35053544

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H53 Visual disturbances	0.060	0.940	0.000
H53.1 Subjective visual disturbances	0.057	0.943	0.000
H53.8 Other visual disturbances	0.056	0.944	0.000
H53.2 Diplopia	0.054	0.946	0.000
H53.0 Amblyopia ex anopsia	0.054	0.946	0.000
H53.6 Night blindness	0.043	0.957	0.000
H53.5 Colour vision deficiencies	0.043	0.957	0.000
H53.3 Other disorders of binocular vision	0.043	0.957	0.000
H53.4 Visual field defects	0.042	0.958	0.000
H53-H54 Visual disturbances and blindness	0.040	0.960	0.000
H53.9 Visual disturbance, unspecified	0.039	0.960	0.000
C91.1 Chronic lymphocytic leukaemia	0.039	0.961	0.000
H54 Blindness and low vision	0.036	0.964	0.000
C83.3 Large cell (diffuse)	0.035	0.964	0.000
H54.9 Unspecified visual impairment (binocular)	0.034	0.966	0.000
C91 Lymphoid leukaemia	0.033	0.967	0.000
K91.4 Colostomy and enterostomy malfunction	0.032	0.968	0.000
H54.0 Blindness, both eyes	0.031	0.969	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.031	0.969	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.030	0.970	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.026	0.974	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.026	0.974	0.000
H54.6 Unqualified visual loss, one eye	0.026	0.974	0.000
H54.5 Low vision, one eye	0.026	0.974	0.000
H54.3 Unqualified visual loss, both eyes	0.026	0.974	0.000
H54.2 Low vision, both eyes	0.026	0.974	0.000
H54.1 Blindness, one eye, low vision, other eye	0.026	0.974	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.025	0.975	0.000
C83.1 Small cleaved cell (diffuse)	0.024	0.976	0.000
C92 Myeloid leukaemia	0.024	0.976	0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.024	0.976	0.000
C91.9 Lymphoid leukaemia, unspecified	0.023	0.976	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.023	0.976	0.000
C91.7 Other lymphoid leukaemia	0.023	0.976	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.023	0.976	0.000
C91.5 Adult T-cell leukaemia	0.023	0.976	0.000
C91.3 Prolymphocytic leukaemia	0.023	0.976	0.000
C91.2 Subacute lymphocytic leukaemia	0.023	0.976	0.000
Z93.2 Ileostomy status	0.023	0.977	0.000
K91.3 Postoperative intestinal obstruction	0.023	0.977	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.022	0.978	0.000
C83.7 Burkitt's tumour	0.022	0.978	0.000
C83.6 Undifferentiated (diffuse)	0.022	0.978	0.000
C83.5 Lymphoblastic (diffuse)	0.022	0.978	0.000
C83.4 Immunoblastic (diffuse)	0.022	0.978	0.000
C83.2 Mixed small and large cell (diffuse)	0.022	0.978	0.000
C91.4 Hairy-cell leukaemia	0.022	0.978	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.022	0.978	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.021	0.978	0.000
C94 Other leukaemias of specified cell type	0.021	0.978	0.000
C93 Monocytic leukaemia	0.021	0.978	0.000
C86 Other specified types of T/NK-cell lymphoma	0.021	0.978	0.000
K91.9 Postprocedural disorder of digestive system, unspecified	0.021	0.979	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.021	0.979	0.000
C95 Leukaemia of unspecified cell type	0.021	0.979	0.000
C92.1 Chronic myeloid leukaemia	0.021	0.979	0.000
H54.4 Blindness, one eye	0.021	0.979	0.000
C91.0 Acute lymphoblastic leukaemia	0.020	0.979	0.000
C88 Malignant immunoproliferative diseases	0.020	0.980	0.000
C85.1 B-cell lymphoma, unspecified	0.020	0.980	0.000
K91.1 Postgastric surgery syndromes	0.020	0.980	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.020	0.980	0.000
C82.0 Small cleaved cell, follicular	0.019	0.980	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.019	0.981	0.000
K91.5 Postcholecystectomy syndrome	0.019	0.981	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.019	0.981	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.019	0.981	0.000
C82.6 Cutaneous follicle centre lymphoma	0.019	0.981	0.000
C82.5 Diffuse follicle centre lymphoma	0.019	0.981	0.000
C82.4 Follicular lymphoma grade IIIb	0.019	0.981	0.000
C82.3 Follicular lymphoma grade IIIa	0.019	0.981	0.000
C82.2 Large cell, follicular	0.019	0.981	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.019	0.981	0.000
C83.0 Small cell (diffuse)	0.019	0.981	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.018	0.982	0.000
C85.0 Lymphosarcoma	0.018	0.982	0.000
C92.9 Myeloid leukaemia, unspecified	0.017	0.982	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.017	0.982	0.000
C92.7 Other myeloid leukaemia	0.017	0.982	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.017	0.982	0.000
C92.5 Acute myelomonocytic leukaemia	0.017	0.982	0.000
C92.4 Acute promyelocytic leukaemia	0.017	0.982	0.000
C92.3 Myeloid sarcoma	0.017	0.982	0.000
C92.2 Subacute myeloid leukaemia	0.017	0.982	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.017	0.983	0.000
K91.0 Vomiting following gastro-intestinal surgery	0.016	0.984	0.000
C92.0 Acute myeloid leukaemia	0.016	0.984	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.016	0.984	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.016	0.984	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.016	0.984	0.000
C86.4 Blastic NK-cell lymphoma	0.016	0.984	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.016	0.984	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.016	0.984	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.016	0.984	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.016	0.984	0.000
C93.9 Monocytic leukaemia, unspecified	0.016	0.984	0.000
C93.7 Other monocytic leukaemia	0.016	0.984	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.016	0.984	0.000
C93.2 Subacute monocytic leukaemia	0.016	0.984	0.000
C93.1 Chronic monocytic leukaemia	0.016	0.984	0.000
C93.0 Acute monocytic leukaemia	0.016	0.984	0.000
C94.7 Other specified leukaemias	0.016	0.984	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.016	0.984	0.000
C94.5 Acute myelofibrosis	0.016	0.984	0.000
C94.4 Acute panmyelosis	0.016	0.984	0.000
C94.3 Mast cell leukaemia	0.016	0.984	0.000
C94.2 Acute megakaryoblastic leukaemia	0.016	0.984	0.000
C94.1 Chronic erythraemia	0.016	0.984	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.016	0.984	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.016	0.984	0.000
C96.8 Histiocytic sarcoma	0.016	0.984	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.016	0.984	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.016	0.984	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.016	0.984	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.016	0.984	0.000
C96.3 True histiocytic lymphoma	0.016	0.984	0.000
C96.2 Malignant mast cell tumour	0.016	0.984	0.000
C96.1 Malignant histiocytosis	0.016	0.984	0.000
C96.0 Letterer-Siwe disease	0.016	0.984	0.000
C95.7 Other leukaemia of unspecified cell type	0.015	0.984	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.015	0.984	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.015	0.984	0.000
C95.0 Acute leukaemia of unspecified cell type	0.015	0.984	0.000
C81 Hodgkin's disease	0.015	0.985	0.000
C95.9 Leukaemia, unspecified	0.015	0.985	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.015	0.985	0.000
C88.7 Other malignant immunoproliferative diseases	0.015	0.985	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.015	0.985	0.000
C88.3 Immunoproliferative small intestinal disease	0.015	0.985	0.000
C88.2 Gamma heavy chain disease	0.015	0.985	0.000
C88.1 Alpha heavy chain disease	0.015	0.985	0.000
H54.7 Unspecified visual loss	0.015	0.985	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.014	0.985	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.014	0.985	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.014	0.985	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.014	0.985	0.000
C84.5 Other and unspecified T-cell lymphomas	0.014	0.985	0.000
C84.3 Lymphoepithelioid lymphoma	0.014	0.985	0.000
C84.2 T-zone lymphoma	0.014	0.985	0.000
C84.1 Sezary's diease	0.014	0.985	0.000
C84.0 Mycosis fungoides	0.014	0.985	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.013	0.986	0.000
C84.4 Peripheral T-cell lymphoma	0.013	0.987	0.000
C90.2 Plasmacytoma, extramedullary	0.012	0.988	0.000
C90.3 Solitary plasmacytoma	0.011	0.988	0.000
C90.1 Plasma cell leukaemia	0.011	0.988	0.000
C81.7 Other Hodgkin's disease	0.011	0.989	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.011	0.989	0.000
C81.3 Lymphocytic depletion	0.011	0.989	0.000
C81.2 Mixed cellularity	0.011	0.989	0.000
C81.0 Lymphocytic predominance	0.011	0.989	0.000
S52.10 Fracture of upper end of radius (closed)	0.010	0.990	0.000
C81.1 Nodular sclerosis	0.008	0.991	0.000
C81.9 Hodgkin's disease, unspecified	0.008	0.991	0.000
Y42.5 Other oestrogens and progestogens	0.008	0.992	0.000
H01.0 Blepharitis	0.008	0.992	0.000
H01 Other inflammation of eyelid	0.007	0.993	0.000
S82.40 Fracture of fibula alone (closed)	0.000	0.993	0.007
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.007	0.993	0.000
H06.2 Dysthyroid exophthalmos	0.007	0.993	0.000
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.007	0.993	0.000
Chapter VII Diseases of the eye and adnexa	0.007	0.993	0.000
H04.5 Stenosis and insufficiency of lachrymal passages	0.006	0.994	0.000
H04 Disorders of lachrymal system	0.006	0.994	0.000
Y40 Systemic antibiotics	0.006	0.994	0.000
E21.0 Primary hyperparathyroidism	0.000	0.994	0.006
Y40.9 Systemic antibiotic, unspecified	0.006	0.994	0.000
S82.80 Fractures of other parts of lower leg (closed)	0.000	0.994	0.006
Y40.1 Cefalosporins and other -lactam antibiotics	0.006	0.994	0.000
H01.9 Inflammation of eyelid, unspecified	0.006	0.994	0.000
F10.1 Harmful use	0.000	0.994	0.006
H04.4 Chronic inflammation of lachrymal passages	0.006	0.994	0.000
Y40.3 Macrolides	0.005	0.994	0.000
S82.4 Fracture of fibula alone	0.000	0.995	0.005
H01.1 Non-infectious dermatoses of eyelid	0.005	0.995	0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.005	0.995	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.005	0.995	0.000
E21.3 Hyperparathyroidism, unspecified	0.000	0.995	0.005
Y40.7 Antifungal antibiotics, systemically used	0.005	0.995	0.000
Y40.0 Penicillins	0.005	0.995	0.000
H06.3 Other disorders of orbit in diseases classified elsewhere	0.005	0.995	0.000
H06.1 Parasitic infestation of orbit in diseases classified elsewhere	0.005	0.995	0.000
H06.0 Disorders of lachrymal system in diseases classified elsewhere	0.005	0.995	0.000
F10.2 Dependence syndrome	0.000	0.995	0.005
H03 Disorders of eyelid in diseases classified elsewhere	0.005	0.995	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.995	0.005
H50 Other strabismus	0.005	0.995	0.000
H01.8 Other specified inflammation of eyelid	0.005	0.995	0.000
H49 Paralytic strabismus	0.005	0.995	0.000
H05 Disorders of orbit	0.005	0.995	0.000
H04.9 Disorder of lachrymal system, unspecified	0.005	0.995	0.000
S52.1 Fracture of upper end of radius	0.005	0.995	0.000
H04.6 Other changes in lachrymal passages	0.005	0.995	0.000
H04.0 Dacryoadenitis	0.005	0.995	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.000	0.995	0.005
H50.9 Strabismus, unspecified	0.005	0.995	0.000
H00 Hordeolum and chalazion	0.005	0.995	0.000
H04.1 Other disorders of lachrymal gland	0.005	0.995	0.000
H46-H48 Disorders of optic nerve and visual pathways	0.005	0.995	0.000
H49.0 Third [oculomotor] nerve palsy	0.005	0.995	0.000
Y40.6 Rifamycins	0.005	0.995	0.000
Y40.5 Aminoglycosides	0.005	0.995	0.000
Y40.4 Tetracyclines	0.005	0.995	0.000
Y40.2 Chloramphenicol group	0.005	0.995	0.000
H55-H59 Other disorders of eye and adnexa	0.005	0.995	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.005	0.995	0.000
H10-H13 Disorders of conjunctiva	0.005	0.995	0.000
H04.8 Other disorders of lachrymal system	0.005	0.995	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.004	0.995	0.000
H50.0 Convergent concomitant strabismus	0.004	0.996	0.000
S82.8 Fractures of other parts of lower leg	0.000	0.996	0.004
C90.0 Multiple myeloma	0.004	0.996	0.001
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
F10.4 Withdrawal state with delirium	0.000	0.996	0.004
S82.41 Fracture of fibula alone (open)	0.000	0.996	0.004
H51 Other disorders of binocular movement	0.004	0.996	0.000
H43-H45 Disorders of vitreous body and globe	0.004	0.996	0.000
H00.1 Chalazion	0.004	0.996	0.000
H44.0 Purulent endophthalmitis	0.004	0.996	0.000
Y42.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
Y42.4 Oral contraceptives	0.004	0.996	0.000
Y42.2 Antithyroid drugs	0.004	0.996	0.000
Y42.1 Thyroid hormones and substitutes	0.004	0.996	0.000
Y42.7 Androgens and anabolic congeners	0.004	0.996	0.000
S82 Fracture of lower leg, including ankle	0.000	0.996	0.004
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.996	0.004
H57 Other disorders of eye and adnexa	0.004	0.996	0.000
H40-H42 Glaucoma	0.004	0.996	0.000
H49.1 Fourth [trochlear] nerve palsy	0.004	0.996	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
K90-K93 Other diseases of the digestive system	0.004	0.996	0.000
H05.2 Exophthalmic conditions	0.004	0.996	0.000
F03 Unspecified dementia	0.004	0.996	0.000
H03.8 Involvement of eyelid in other diseases classified elsewhere	0.004	0.996	0.000
H03.0 Parasitic infestation of eyelid in diseases classified elsewhere	0.004	0.996	0.000
S82.1 Fracture of upper end of tibia	0.000	0.996	0.004
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.996	0.004
E21.4 Other specified disorders of parathyroid gland	0.000	0.996	0.004
E21.2 Other hyperparathyroidism	0.000	0.996	0.004
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.004	0.996	0.000
S82.10 Fracture of upper end of tibia (closed)	0.000	0.996	0.004
H49.9 Paralytic strabismus, unspecified	0.004	0.996	0.000
H49.8 Other paralytic strabismus	0.004	0.996	0.000
H49.4 Progressive external ophthalmoplegia	0.004	0.996	0.000
H49.3 Total (external) ophthalmoplegia	0.004	0.996	0.000
H50.8 Other specified strabismus	0.004	0.996	0.000
H50.6 Mechanical strabismus	0.004	0.996	0.000
H50.4 Other and unspecified heterotropia	0.004	0.996	0.000
H50.3 Intermittent heterotropia	0.004	0.996	0.000
F10.3 Withdrawal state	0.000	0.996	0.004
H05.9 Disorder of orbit, unspecified	0.004	0.996	0.000
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.004	0.996	0.000
H05.4 Enophthalmos	0.004	0.996	0.000
H05.3 Deformity of orbit	0.004	0.996	0.000
H05.1 Chronic inflammatory disorders of orbit	0.004	0.996	0.000
Z00.0 General medical examination	0.004	0.996	0.000
H50.5 Heterophoria	0.004	0.996	0.000
H44 Disorders of globe	0.004	0.996	0.000
Y46.6 Other and unspecified antiepileptics	0.004	0.996	0.000
S52.11 Fracture of upper end of radius (open)	0.004	0.996	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.004	0.996	0.000
F10.9 Unspecified mental and behavioural disorder	0.000	0.996	0.004
F10.8 Other mental and behavioural disorders	0.000	0.996	0.004
F10.7 Residual and late-onset psychotic disorder	0.000	0.996	0.004
F10.6 Amnesic syndrome	0.000	0.996	0.004
F10.5 Psychotic disorder	0.000	0.996	0.004
H49.2 Sixth [abducent] nerve palsy	0.004	0.996	0.000
H05.8 Other disorders of orbit	0.004	0.996	0.000
X41.9 Unspecified place	0.004	0.996	0.000
H03.1 Involvement of eyelid in other infectious diseases classified elsewhere	0.003	0.996	0.000
Y45.2 Propionic acid derivatives	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.004	0.996	0.000
H57.1 Ocular pain	0.004	0.996	0.000
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere	0.003	0.996	0.000
Y59 Other and unspecified vaccines and biological substances	0.004	0.996	0.000
Y58 Bacterial vaccines	0.004	0.996	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.004	0.996	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.996	0.000
Y46.4 Iminostilbenes	0.004	0.996	0.000
H13 Disorders of conjunctiva in diseases classified elsewhere	0.003	0.996	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.996	0.000
Y44 Agents primarily affecting blood constituents	0.004	0.996	0.000
H10 Conjunctivitis	0.003	0.996	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.003	0.996	0.000
Z93 Artificial opening status	0.004	0.996	0.000
H34.2 Other retinal artery occlusions	0.004	0.996	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.996	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.996	0.000
H57.0 Anomalies of pupillary function	0.003	0.996	0.000
S82.3 Fracture of lower end of tibia	0.000	0.996	0.003
H50.1 Divergent concomitant strabismus	0.003	0.996	0.000
Y40.8 Other systemic antibiotics	0.003	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
S82.86 Maisonneuve's fracture	0.000	0.997	0.003
H57.9 Disorder of eye and adnexa, unspecified	0.003	0.997	0.000
H46 Optic neuritis	0.003	0.997	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
H50.2 Vertical strabismus	0.003	0.997	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.003	0.997	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.003	0.997	0.000
H05.0 Acute inflammation of orbit	0.003	0.997	0.000
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
H11.3 Conjunctival haemorrhage	0.003	0.997	0.000
H34 Retinal vascular occlusions	0.003	0.997	0.000
H51.9 Disorder of binocular movement, unspecified	0.003	0.997	0.000
H51.8 Other specified disorders of binocular movement	0.003	0.997	0.000
H51.2 Internuclear ophthalmoplegia	0.003	0.997	0.000
H51.1 Convergence insufficiency and excess	0.003	0.997	0.000
H51.0 Palsy of conjugate gaze	0.003	0.997	0.000
Y46.2 Hydantoin derivatives	0.003	0.997	0.000
H11 Other disorders of conjunctiva	0.003	0.997	0.000
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.003	0.997	0.000
S82.9 Fracture of lower leg, part unspecified	0.000	0.997	0.003
Z93.4 Other artificial openings of gastro-intestinal tract status	0.003	0.997	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.003	0.997	0.000
D04.3 Skin of other and unspecified parts of face	0.003	0.997	0.000
S82.2 Fracture of shaft of tibia	0.000	0.997	0.003
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
H42 Glaucoma in diseases classified elsewhere	0.003	0.997	0.000
F10.0 Acute intoxication	0.000	0.997	0.003
K93 Disorders of other digestive organs in diseases classified elsewhere	0.003	0.997	0.000
S82.30 Fracture of lower end of tibia (closed)	0.000	0.997	0.003
S82.11 Fracture of upper end of tibia (open)	0.000	0.997	0.003
H58.9 Other specified disorders of eye and adnexa in diseases classified elsewhere	0.003	0.997	0.000
H58.1 Visual disturbances in diseases classified elsewhere	0.003	0.997	0.000
H58.0 Anomalies of pupillary function in diseases classified elsewhere	0.003	0.997	0.000
K86.1 Other chronic pancreatitis	0.003	0.997	0.000
Z03.1 Observation for suspected malignant neoplasm	0.000	0.997	0.003
N87.0 Mild cervical dysplasia	0.003	0.997	0.000
S82.5 Fracture of medial malleolus	0.000	0.997	0.003
S82.7 Multiple fractures of lower leg	0.000	0.997	0.003
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
H02 Other disorders of eyelid	0.003	0.997	0.000
H44.9 Disorder of globe, unspecified	0.003	0.997	0.000
H44.8 Other disorders of globe	0.003	0.997	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.003	0.997	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.003	0.997	0.000
H44.5 Degenerated conditions of globe	0.003	0.997	0.000
H44.4 Hypotony of eye	0.003	0.997	0.000
H44.3 Other degenerative disorders of globe	0.003	0.997	0.000
H44.1 Other endophthalmitis	0.003	0.997	0.000
H02.4 Ptosis of eyelid	0.003	0.997	0.000
H02.1 Ectropion of eyelid	0.003	0.997	0.000
H10.4 Chronic conjunctivitis	0.003	0.997	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.003	0.997	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.003	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
Y45.4 Antirheumatics	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
H30-H36 Disorders of choroid and retina	0.003	0.997	0.000
Z00.5 Examination of potential donor of organ and tissue	0.003	0.997	0.000
X45 Accidental poisoning by and exposure to alcohol	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
Y54.5 Other diuretics	0.003	0.997	0.000
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances	0.003	0.997	0.000
H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere	0.003	0.997	0.000
H48.1 Retrobulbar neuritis in diseases classified elsewhere	0.003	0.997	0.000
H48.0 Optic atrophy in diseases classified elsewhere	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
H13.8 Other disorders of conjunctiva in diseases classified elsewhere	0.003	0.997	0.000
H13.3 Ocular pemphigoid	0.003	0.997	0.000
H13.2 Conjunctivitis in other diseases classified elsewhere	0.003	0.997	0.000
H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
H13.0 Filarial infection of conjunctiva	0.003	0.997	0.000
H47.1 Papilloedema, unspecified	0.003	0.997	0.000
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
Y55.5 Anticommon cold drugs	0.003	0.997	0.000
Y55.4 Expectorants	0.003	0.997	0.000
Y55.3 Antitussives	0.003	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
Y55.0 Oxytocic drugs	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
Y58.0 BCG vaccine	0.003	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.003	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.003	0.997	0.000
Y59.2 Protozoal vaccines	0.003	0.997	0.000
Y59.1 Rickettsial vaccines	0.003	0.997	0.000
Y59.0 Viral vaccines	0.003	0.997	0.000
D04 Carcinoma in situ of skin	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
D04.7 Skin of lower limb, including hip	0.003	0.997	0.000
H47.3 Other disorders of optic disk	0.003	0.997	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.997	0.000
Y44.7 Plasma substitutes	0.003	0.997	0.000
Y44.6 Natural blood and blood products	0.003	0.997	0.000
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.997	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.997	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.997	0.000
H55 Nystagmus and other irregular eye movements	0.003	0.997	0.000
H10.8 Other conjunctivitis	0.003	0.997	0.000
H10.5 Blepharoconjunctivitis	0.003	0.997	0.000
H10.3 Acute conjunctivitis, unspecified	0.003	0.997	0.000
H10.2 Other acute conjunctivitis	0.003	0.997	0.000
H10.1 Acute atopic conjunctivitis	0.003	0.997	0.000
H10.0 Mucopurulent conjunctivitis	0.003	0.997	0.000
Y49.5 Other antipsychotics and neuroleptics	0.003	0.997	0.000
Z93.9 Artificial opening status, unspecified	0.003	0.997	0.000
Z93.8 Other artificial opening status	0.003	0.997	0.000
H15 Disorders of sclera	0.003	0.997	0.000
K90 Intestinal malabsorption	0.003	0.997	0.000
Z00 General examination and investigation of persons without complaint or reported diagnosis	0.003	0.997	0.000
H47.7 Disorder of visual pathways, unspecified	0.003	0.997	0.000
H47.6 Disorders of visual cortex	0.003	0.997	0.000
H47.5 Disorders of other visual pathways	0.003	0.997	0.000
H47.4 Disorders of optic chiasm	0.003	0.997	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.003	0.997	0.000
Y41.4 Anthelminthics	0.003	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.003	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.003	0.997	0.000
Y48.3 Local anaesthetics	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
Y54.7 Agents affecting calcification	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
Y54.0 Mineralocorticoids	0.003	0.997	0.000
S82.21 Fracture of shaft of tibia (open)	0.000	0.997	0.003
H04.2 Epiphora	0.003	0.997	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.003	0.997	0.000
Y44.2 Anticoagulants	0.003	0.997	0.000
H34.9 Retinal vascular occlusion, unspecified	0.003	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
X45.0 Home	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
Z93.5 Cystostomy status	0.003	0.997	0.000
X49.9 Unspecified place	0.003	0.997	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
T17.2 Foreign body in pharynx	0.003	0.997	0.000
X41.0 Home	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations